We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAVEW icon
601
Dave Inc Warrants
DAVEW
$13.3M
$1K ﹤0.01%
+23,427
New +$2.17K
MO icon
602
Altria Group
MO
$109B
$1K ﹤0.01%
+25,300
New +$1.1M
DHAIW
603
DELISTED
DIH Holding US Inc Warrants
DHAIW
$1K ﹤0.01%
39,500
-3,500
-8% -$107
VEEAW
604
Veea Inc Warrant
VEEAW
$504K
$1K ﹤0.01%
+11,300
New +$1.56K
YOTAR
605
DELISTED
Yotta Acquisition Corporation Right
YOTAR
$1K ﹤0.01%
24,000
-1,000
-4% -$78
KACLW
606
DELISTED
Kairous Acquisition Corp. Limited Warrants
KACLW
$1K ﹤0.01%
+19,950
New +$1.35K
CLOER
607
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$1K ﹤0.01%
+24,700
New +$1.63K
BLUA.WS
608
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$1K ﹤0.01%
+16,666
New +$1.28K
QDROW
609
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$1K ﹤0.01%
19,632
+3,132
+19% +$183
CSTA.WS
610
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$1K ﹤0.01%
14,252
FSRXW
611
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$1K ﹤0.01%
+21,649
New +$1.89K
MTRYW
612
DELISTED
Monterey Innovation Acquisition Corp. Warrant
MTRYW
$1K ﹤0.01%
+19,100
New +$1.1K
VMGAW
613
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
$1K ﹤0.01%
+11,857
New +$1.57K
BMAQW
614
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
$1K ﹤0.01%
41,760
-14,900
-26% -$785
FRONW
615
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$1K ﹤0.01%
15,950
ITQRW
616
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
$1K ﹤0.01%
50,000
CTAQW
617
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
$1K ﹤0.01%
+15,000
New +$1.68K
FOXWW
618
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$1K ﹤0.01%
14,975
+100
+0.7% +$5
AEACW
619
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$1K ﹤0.01%
+25,000
New +$1.73K
DLCAW
620
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$1K ﹤0.01%
26,932
BRMK.WS
621
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$1K ﹤0.01%
+19,700
New +$1.42K
CZOO.WS
622
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
$1K ﹤0.01%
+25,000
New +$2.27K
KAIRW
623
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1K ﹤0.01%
+19,979
New +$1.02K
FTVIW
624
DELISTED
FinTech Acquisition Corp. VI Warrants
FTVIW
$1K ﹤0.01%
24,273
+6,250
+35% +$628
SPTKW
625
DELISTED
SportsTek Acquisition Corp. Warrant
SPTKW
$1K ﹤0.01%
29,800

Similar funds

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.